Sweden· SE-20150630000018
Attentin 10 mg Tablett
A medicinal product containing dexamfetamine sulfate, registered in Sweden by Medice Arzneimittel Pütter GmbH & Co. KG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Dexamfetamine Sulfate
- Manufacturer
- Medice Arzneimittel Pütter GmbH & Co. KG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20150630000018
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamfetamine sulfate in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDextroamphetamine SulfateLupin Pharmaceuticals,Inc.
- FinlandAttadexAbboxia AB
- NetherlandsAttenfarm 10 mg tablettenOrifarm Healthcare A/S
- NorwayAttentinMedice Arzneimittel Pütter GmbH & Co KG
- IcelandAttentinMedice Arzneimittel Pütter GmbH & Co. KG*
- SwitzerlandAttentin
- PolandTentinMedice Arzneimittel Puetter GmbH & Co. KG
- FranceTENTIN 10 mg, compriméMEDICE ARZNEIMITTEL PÜTTER (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Philla
- Belgium · Adhesa, Attentin
- Germany · Attentin, Dexamfetamin Orifarm
- Denmark · Adhesa, Attentin
- Estonia · Tentin
- Spain · Tentin
- Finland · Adhesa 5 Mg Tabletti, Attadex
- France · Tentin
- United Kingdom (Northern Ireland) · Amfexa, Dexamfetamine Sulfate
- Iceland · Attentin, Dexamfetamine Taw Pharma (Ireland)
- Italy · Amfexa
- Luxembourg · Attentin
- Malta · Dexamfetamine Sulfate
- Netherlands · Adhesa, Attenfarm
- Norway · Attentin, Deksamfetamin Waymade B.V.
- Poland · Tentin
- Portugal · Tentin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b54f178e-ee0e-4d08-a3c6-2a08d50c2caf GET /v1/drugs/b54f178e-ee0e-4d08-a3c6-2a08d50c2caf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL",
"sRMP"
],
"se_npl_id": "20150630000018",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20150630000018",
"product_doc_link": "https://docetp.mpa.se/LMF/Attentin%20tablet%20ENG%20SmPC_09001bee846ce9e5.pdf"
}See everything about dexamfetamine sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.